Elomotecan Hydrochloride

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameElomotecan Hydrochloride
Drug Alias Nameelomotecanum依罗替康盐酸盐依洛替康盐酸盐盐酸依罗替康盐酸依洛替康 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsDNA topoisomerase I inhibitors
TargetsTopoisomerase IIDNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A